Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test [Yahoo! Finance]
Biomerica Announces CMS Medicare Payment Rate of $300 for Revolutionary inFoods® IBS Test
Egyptian Drug Authority Authorizes Biomerica's Complete Screening Test Portfolio [Yahoo! Finance]
Egyptian Drug Authority Authorizes Biomerica’s Complete Screening Test Portfolio
Biomerica's inFoods® IBS Product Featured in Biotherapeutics Quarterly, a Henry Schein Publication, Highlighting a New Precision Approach for Treating IBS [Yahoo! Finance]